| Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ... Movement Disorders 32 (6), 853-864, 2017 | 1020 | 2017 |
| Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society KP Bhatia, P Bain, N Bajaj, RJ Elble, M Hallett, ED Louis, J Raethjen, ... Movement Disorders 33 (1), 75-87, 2018 | 580 | 2018 |
| Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy JA Obeso, M Stamelou, CG Goetz, W Poewe, AE Lang, D Weintraub, ... Movement Disorders 32 (9), 1264-1310, 2017 | 540 | 2017 |
| Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy GU Höglinger, NM Melhem, DW Dickson, P Sleiman, LS Wang, L Klei, ... Nature genetics 43 (7), 699-705, 2011 | 504 | 2011 |
| Dopaminergic reward system: a short integrative review O Arias-Carrión, M Stamelou, E Murillo-Rodríguez, ... International archives of medicine 3 (1), 1-6, 2010 | 478 | 2010 |
| The non-motor syndrome of primary dystonia: clinical and pathophysiological implications M Stamelou, MJ Edwards, M Hallett, KP Bhatia Brain 135 (6), 1668-1681, 2012 | 277 | 2012 |
| The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases G Respondek, M Stamelou, C Kurz, LW Ferguson, A Rajput, WZ Chiu, ... Movement Disorders 29 (14), 1758-1766, 2014 | 261 | 2014 |
| A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy. DST Tolosa E, Litvan I, Höglinger GU, Burn D, Lees A, T Investigators. Movement Disorders Journal 29 (4), 470-478, 2014 | 249* | 2014 |
| Reward pays the cost of noise reduction in motor and cognitive control SG Manohar, TTJ Chong, MAJ Apps, A Batla, M Stamelou, PR Jarman, ... Current Biology 25 (13), 1707-1716, 2015 | 237 | 2015 |
| Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis G Charlesworth, V Plagnol, KM Holmström, J Bras, UM Sheerin, E Preza, ... The American Journal of Human Genetics 91 (6), 1041-1050, 2012 | 227 | 2012 |
| Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers NE Mencacci, IU Isaias, MM Reich, C Ganos, V Plagnol, JM Polke, J Bras, ... Brain 137 (9), 2480-2492, 2014 | 178 | 2014 |
| The expanding universe of disorders of the basal ganglia JA Obeso, MC Rodriguez-Oroz, M Stamelou, KP Bhatia, DJ Burn The Lancet 384 (9942), 523-531, 2014 | 175 | 2014 |
| AFQ056 treatment of levodopa‐induced dyskinesias: results of 2 randomized controlled trials D Berg, J Godau, C Trenkwalder, K Eggert, II Csoti, A Storch, H Huber, ... Movement Disorders 26 (7), 1243-1250, 2011 | 175 | 2011 |
| PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine AR Gardiner, KP Bhatia, M Stamelou, RC Dale, MA Kurian, SA Schneider, ... Neurology 79 (21), 2115-2121, 2012 | 174 | 2012 |
| The Parkinson's progression markers initiative (PPMI)–establishing a PD biomarker cohort K Marek, S Chowdhury, A Siderowf, S Lasch, CS Coffey, ... Annals of clinical and translational neurology 5 (12), 1460-1477, 2018 | 172 | 2018 |
| Short‐term effects of coenzyme Q10 in progressive supranuclear palsy: A randomized, placebo‐controlled trial M Stamelou, A Reuss, U Pilatus, J Magerkurth, P Niklowitz, KM Eggert, ... Movement disorders: official journal of the Movement Disorder Society 23 (7 …, 2008 | 164 | 2008 |
| Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be? JL Whitwell, GU Höglinger, A Antonini, Y Bordelon, AL Boxer, C Colosimo, ... Movement Disorders 32 (7), 955-971, 2017 | 150 | 2017 |
| Continuous jejunal levodopa infusion in patients with advanced Parkinson disease: practical aspects and outcome of motor and non-motor complications K Eggert, C Schrader, M Hahn, M Stamelou, A Rüssmann, R Dengler, ... Clinical neuropharmacology 31 (3), 151-166, 2008 | 146 | 2008 |
| Tremor task force of the international parkinson and movement disorder society KP Bhatia, P Bain, N Bajaj, RJ Elble, M Hallett, ED Louis, J Raethjen, ... Consensus Statement on the classification of tremors. from the task force on …, 2018 | 130 | 2018 |
| The clinical and genetic heterogeneity of paroxysmal dyskinesias AR Gardiner, F Jaffer, RC Dale, R Labrum, R Erro, E Meyer, ... Brain 138 (12), 3567-3580, 2015 | 126 | 2015 |
Kailash BhatiaProfessor of Clinical Neurology, Institute of Neurology, UCL, Queen Square, London WC1N 3BG,Verified email at ucl.ac.uk
